⌘K

Home/Filings/4/0001193125-25-260426

4//SEC Filing

Chawla Lakhmir S 4

Accession 0001193125-25-260426

CIK 0001810560other

View on SEC.gov Company Profile

Filed

Oct 30, 8:00 PM ET

Accepted

Oct 31, 1:01 PM ET

Size

5.2 KB

Accession

0001193125-25-260426

Insider Transaction Report

Form 4

Period: 2025-10-29

REVELATION BIOSCIENCES, INC.REVB

Chawla Lakhmir S

Director

Transactions

Award
Common Stock
2025-10-29$1.28/sh+15,625$20,000→ 15,686 total

Holdings

Common Stock
61

Footnotes (1)

[F1]Restricted Stock Grant under the 2021 Equity Incentive Plan. Vests 100% on January 28, 2026.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

REVELATION BIOSCIENCES, INC.

CIK 0001810560

Entity typeother

Related Parties

1

filerCIK 0001646626

Filing Metadata

Form type: 4
Filed: Oct 30, 8:00 PM ET
Accepted: Oct 31, 1:01 PM ET
Size: 5.2 KB

View on SEC.gov